{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:00:23Z","timestamp":1794866423788,"version":"4.9.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["192123"],"award-info":[{"award-number":["192123"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020434","name":"McMaster Institute for Research on Aging, McMaster University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128160","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T21:55:40Z","timestamp":1767218140000},"page":"128160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Humoral and cellular immunogenicity of sequential heterogeneous bivalent SARS-CoV-2 vaccinations in long-term care and retirement home residents"],"prefix":"10.1016","volume":"73","author":[{"given":"Jessica A.","family":"Breznik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann C.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Bhakta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Bilaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison E.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braeden","family":"Cowbrough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Rahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumi","family":"Clare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Bramson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishac","family":"Nazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.E.","family":"Bowdish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128160_bb0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41541-024-00874-4","article-title":"Insights into vaccines for elderly individuals: from the impacts of immunosenescence to delivery strategies","volume":"9","author":"Hou","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2025.128160_bb0010","doi-asserted-by":"crossref","first-page":"19143","DOI":"10.1038\/s41598-021-97711-8","article-title":"An international comparison of age and sex dependency of COVID-19 deaths in 2020: a descriptive analysis","volume":"11","author":"Bauer","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.128160_bb0015","author":"Frank"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128160_bb0020","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jamda.2023.02.105","article-title":"Protection from omicron infection in residents of nursing and retirement homes in Ontario","volume":"24","author":"Breznik","year":"2023","journal-title":"Canada J Am Med Dir Assoc"},{"issue":"12","key":"10.1016\/j.vaccine.2025.128160_bb0025","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1016\/j.jamda.2021.10.001","article-title":"Antibody responses 3-5 months post-vaccination with mRNA-1273 or BNT163b2 in nursing home residents","volume":"22","author":"Breznik","year":"2021","journal-title":"J Am Med Dir Assoc"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128160_bb0030","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jamda.2021.12.035","article-title":"Antibody responses to third-dose mRNA vaccines in nursing home and assisted living residents","volume":"23","author":"Zhang","year":"2022","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128160_bb0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S2213-2600(23)00015-2","article-title":"Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022","volume":"11","author":"Wu","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.vaccine.2025.128160_bb0040","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128160_bb0045","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2025.128160_bb0050","article-title":"Waning immunity and IgG4 responses following bivalent mRNA boosting","volume":"10(8):eadj9945","author":"Lasrado","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.vaccine.2025.128160_bb0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJMc2213948","article-title":"Immunogenicity of BA.5 bivalent mRNA vaccine boosters","volume":"388","author":"Collier","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128160_bb0060","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/cid\/ciad209","article-title":"Immunogenicity of the BA.1 and BA.4\/BA.5 severe acute respiratory syndrome coronavirus 2 bivalent boosts: preliminary results from the COVAIL randomized clinical trial","volume":"77","author":"Branche","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128160_bb0065","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/infdis\/jiad472","article-title":"Durability of cross-neutralizing antibodies 5.5 months after bivalent coronavirus disease 2019 vaccine booster","volume":"229","author":"R\u00f6ssler","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128160_bb0070","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41541-023-00708-9","article-title":"Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4\/BA.5) increases neutralization of matched omicron variants","volume":"8","author":"Springer","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2025.128160_bb0075","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41586-023-06025-4","article-title":"SARS-CoV-2 omicron boosting induces de novo B cell response in humans","volume":"617","author":"Alsoussi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.128160_bb0080","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa2213082","article-title":"Bivalent omicron BA.1\u2013adapted BNT162b2 booster in adults older than 55 years","volume":"388","author":"Winokur","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.128160_bb0085","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa2208343","article-title":"A bivalent omicron-containing booster vaccine against Covid-19","volume":"387","author":"Chalkias","year":"2022","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.vaccine.2025.128160_bb0090","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1016\/j.vaccine.2024.04.049","article-title":"A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against omicron variants","volume":"42","author":"Song","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128160_bb0095","author":"National Advisory Committee on Immunization (NACI)"},{"key":"10.1016\/j.vaccine.2025.128160_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29170","article-title":"Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: an observational cohort study","volume":"95","author":"Breznik","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2025.128160_bb0110","author":"Ontario Agency for Health Protection and Promotion (Public Health Ontario) Ontario Immunization Advisory Committee"},{"key":"10.1016\/j.vaccine.2025.128160_bb0115","author":"Ontario Ministry of Health"},{"key":"10.1016\/j.vaccine.2025.128160_bb0120","author":"Ontario Agency for Health Protection and Promotion (Public Health Ontario)"},{"issue":"10","key":"10.1016\/j.vaccine.2025.128160_bb0125","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.4049\/jimmunol.2200369","article-title":"Cytomegalovirus seropositivity in older adults changes the T cell repertoire but does not prevent antibody or cellular responses to SARS-CoV-2 vaccination","volume":"209","author":"Breznik","year":"2022","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128160_bb0130","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/cyto.b.21526","article-title":"A comprehensive assessment of immunophenotyping performed in cryopreserved peripheral whole blood","volume":"94","author":"Verschoor","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128160_bb0135","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/v13040697","article-title":"Characteristics of anti-SARS-CoV-2 antibodies in recovered COVID-19 subjects","volume":"13","author":"Huynh","year":"2021","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.vaccine.2025.128160_bb0140","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.3390\/v13112239","article-title":"Lasting changes to circulating leukocytes in people with mild SARS-CoV-2 infections","volume":"13","author":"Kennedy","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.128160_bb0145","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/s41467-023-37176-7","article-title":"Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis","volume":"14","author":"Cromer","year":"2023","journal-title":"Nat Commun"},{"issue":"6608","key":"10.1016\/j.vaccine.2025.128160_bb0150","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1126\/science.add2897","article-title":"T cell immunity to COVID-19 vaccines","volume":"377","author":"Wherry","year":"2022","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128160_bb0155","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/cid\/ciad718","article-title":"A bivalent omicron-BA.4\/BA.5-adapted BNT162b2 booster in \u226512-year-olds","volume":"78","author":"Usdan","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2025.128160_bb0160","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/cid\/ciad402","article-title":"Omicron variant-specific serological imprinting following BA.1 or BA.4\/5 bivalent vaccination and previous SARS-CoV-2 infection: a cohort study","volume":"77","author":"Baerends","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"6577","key":"10.1016\/j.vaccine.2025.128160_bb0165","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1126\/science.abm0811","article-title":"Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants","volume":"375","author":"Reynolds","year":"2022","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.vaccine.2025.128160_bb0170","article-title":"Deep immunological imprinting due to the ancestral spike in the current bivalent COVID-19 vaccine","volume":"4","author":"Wang","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.vaccine.2025.128160_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102148","article-title":"Early omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities","volume":"63","author":"Breznik","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"23","key":"10.1016\/j.vaccine.2025.128160_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.05.074","volume":"42","author":"Fabiani","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128160_bb0185","article-title":"Effectiveness and durability of mRNA-1273 BA.4\/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4\/BA.5 and XBB sublineages","volume":"20(1):2335052","author":"Ackerson","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128160_bb0190","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/infdis\/jiad419","article-title":"Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against omicron severe outcomes among adults aged \u226550 years in Ontario, Canada: a Canadian immunization research network study","volume":"229","author":"Grewal","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128160_bb0195","article-title":"Vaccine effectiveness against hospitalisation estimated using a test-negative case-control study design, and comparative odds of hospital admission and severe outcomes with COVID-19 sub-lineages BQ.1, CH.1.1. And XBB.1.5 in England","volume":"35","author":"Kirsebom","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"7","key":"10.1016\/j.vaccine.2025.128160_bb0200","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.7.2400076","article-title":"2023\/24 mid-season influenza and omicron XBB.1.5 vaccine effectiveness estimates from the Canadian sentinel practitioner surveillance network (SPSN)","volume":"29","author":"Skowronski","year":"2024","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128160_bb0205","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1093\/infdis\/jiaf022","article-title":"Safety and immunogenicity of SARS-CoV-2 spike receptor-binding domain and N-terminal domain mRNA vaccine","volume":"231","author":"Chalkias","year":"2025","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128160_bb0210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40520-025-02990-0","article-title":"COVID-19 booster doses reduce sex disparities in antibody responses among nursing home residents","volume":"37","author":"Oyebanji","year":"2025","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.vaccine.2025.128160_bb0215","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12979-024-00476-7","article-title":"Health characteristics associated with persistence of SARS-CoV-2 antibody responses after repeated vaccinations in older persons over time: the Doetinchem cohort study","volume":"21","author":"Kuijpers","year":"2024","journal-title":"Immun Ageing"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128160_bb0220","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/infdis\/jiae234","article-title":"Longitudinal analysis of nursing home residents\u2019 T-cell responses after SARS-CoV-2 mRNA vaccinations shows influence of biological sex and infection history","volume":"230","author":"Smith","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128160_bb0225","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s11739-023-03283-y","article-title":"Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid vax study","volume":"18","author":"Trevisan","year":"2023","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.vaccine.2025.128160_bb0230","article-title":"Association of frailty, age, and biological sex with severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine\u2013induced immunity in older adults","volume":"75(S_1):S61-S71","author":"Shapiro","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2025.128160_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049715","article-title":"Th17 effector cells support B cell responses outside of germinal centres","volume":"7","author":"Patakas","year":"2012","journal-title":"PLoS One"},{"issue":"32","key":"10.1016\/j.vaccine.2025.128160_bb0240","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1073\/pnas.1009234107","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers","volume":"107","author":"Mitsdoerffer","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2025.128160_bb0245","article-title":"Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged \u226550 years in Nordic countries: nationwide cohort study","volume":"382","author":"Andersson","year":"2023","journal-title":"BMJ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:04:40Z","timestamp":1770282280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25014586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":48,"alternative-id":["S0264410X25014586"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128160","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humoral and cellular immunogenicity of sequential heterogeneous bivalent SARS-CoV-2 vaccinations in long-term care and retirement home residents","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128160"}}